Empirically establishing drug exposure records directly from untargeted metabolomics data
bioRxiv [Preprint]. 2024 Oct 26:2024.10.07.617109. doi: 10.1101/2024.10.07.617109.
Published on October 17, 2024
ABSTRACT
Despite extensive efforts, extracting information on medication exposure from clinical records remains challenging. To complement this approach, we developed the tandem mass spectrometry (MS/MS) based GNPS Drug Library. This resource integrates MS/MS data for drugs and their metabolites/analogs with controlled vocabularies on exposure sources, pharmacologic classes, therapeutic indications, and mechanisms of action. It enables direct analysis of drug exposure and metabolism from untargeted metabolomics data independent of clinical records. Our library facilitates stratification of individuals in clinical studies based on the empirically detected medications, exemplified by drug-dependent microbiota-derived N-acyl lipid changes in a cohort with human immunodeficiency virus. The GNPS Drug Library holds potential for broader applications in drug discovery and precision medicine.
PMID:39416075 | PMC:PMC11482764 | DOI:10.1101/2024.10.07.617109
Latest Publications
- Cell viscosity influences haematogenous dissemination and metastatic extravasation of tumour cells
- Progressive fibrosis in human MASLD is associated with spatially linked transcriptomic signatures of metabolic reprogramming and senescence
- The inflammatory path toward type 1 diabetes begins during pregnancy
- Fast label-free live imaging with FlowVision reveals key principles of cancer cell arrest on endothelial monolayers
- Single-cell RNA-seq analysis of longitudinal CD4+ T cell samples reveals cell-type-specific changes during early stages of type 1 diabetes